Neopterin is a biomarker of chronic heart failure (review of modern literature)
Amina M. AlievaPirogov Russian National Research Medical UniversityTatiana V. PinchukPirogov Russian National Research Medical UniversityKira Vladimirovna VoronkovaAssociation of Epileptologists and PatientsШнахова Лидия МухамедовнаSechenov First Moscow State Medical University (Sechenov University)Olga A. EttingerPirogov Russian National Research Medical UniversityMadina F. AkhmedovaMultipurpose Medical Center “AKFA Medline”R. K. ValievLoginov Moscow Clinical Scientific and Practical CenterMarina R. KalovaPirogov Russian National Research Medical UniversityElvina T. GasanovaPirogov Russian National Research Medical UniversityИ. Г. НикитинPirogov Russian National Research Medical University
2021en
Ochiq kirishOlmos
Litsenziya: cc-by-nc-sa
ABI
Annotatsiya
Inflammation plays a role in the pathogenesis of heart failure. Neopterin, pteridine, synthesized mainly by activated macrophages, is a marker of inflammation, activation of the immune system, and an active participant in cardiovascular disease. Measuring neopterin levels can help track the evolution of specific inflammatory conditions. In addition, neopterin was associated with cardiac dysfunction after cardiac surgery and improved the accuracy of predicting the risk of postoperative cardiac dysfunction. In this review, we provide current insights into neopterin and its relationship to heart failure.
Hali tarjima qilinmagan